This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Teruo Kitani: Innovator in Pharmaceutical Preparations
Introduction
Teruo Kitani is a notable inventor based in Suitashi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of metabolic disorders. His innovative approach has led to the development of a unique pharmaceutical preparation that addresses Acylcarnitine Metabolic Dysfunction Syndrome.
Latest Patents
Kitani holds a patent for a pharmaceutical preparation comprising an acylcarnitine. This patent outlines a method for treating Acylcarnitine Metabolic Dysfunction Syndrome by administering an acylcarnitine or a pharmacologically acceptable salt thereof, either orally or parenterally. The acylcarnitine may include various forms such as acetylcarnitine, propionylcarnitine, butyrylcarnitine, isobutyrylcarnitine, valerylcarnitine, isovalerylcarnitine, or hexanoylcarnitine. This innovation showcases his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Teruo Kitani has focused on developing effective pharmaceutical solutions. His work has been instrumental in addressing specific metabolic dysfunctions, thereby improving the quality of life for patients affected by these conditions. His dedication to research and innovation has earned him recognition in the scientific community.
Collaborations
Kitani has collaborated with fellow inventor Hirohiko Kuratsune, contributing to the advancement of pharmaceutical research. Their partnership has fostered a productive environment for innovation and development in the field.
Conclusion
Teruo Kitani's contributions to pharmaceutical preparations highlight his role as a key innovator in the treatment of metabolic disorders. His patent for an acylcarnitine-based preparation demonstrates his commitment to improving healthcare solutions. His work continues to inspire advancements in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile